Abstract

BackgroundQuantification of abdominal muscle mass by cross-sectional imaging has been increasingly used to diagnose sarcopenia; however, the technical method for quantification has not been standardized yet. We aimed to determine an optimal method to measure the abdominal muscle area.MethodsAmong 50 consecutive subjects who underwent abdominal CT and MRI for possible liver donation, total abdominal muscle area (TAMA) and total psoas muscle area (TPA) at the L3 inferior endplate level were measured by two blinded readers. Inter-scan agreement between CT and MRI and inter-reader agreement between the two readers were evaluated using intraclass correlation coefficient (ICC) and within-subject coefficient of variation (WSCV). To evaluate the effect of measurement level, one reader measured TAMA and TPA at six levels from the L2 to L4 vertebral bodies.ResultsTAMA was a more reliable biomarker than TPA in terms of inter-scan agreement (ICC: 0.928 vs. 0.788 for reader 1 and 0.853 vs. 0.821 for reader 2, respectively; WSCV: 8.3% vs. 23.4% for reader 1 and 10.4% vs. 22.3% for reader 2, respectively) and inter-reader agreement (ICC: 0.986 vs. 0.886 for CT and 0.865 vs. 0.669 for MRI, respectively; WSCV: 8.2% vs. 16.0% for CT and 11.6% vs. 29.7% for MRI, respectively). In terms of the measurement level, TAMA did not differ from the L2inf to L4inf levels, whereas TPA increased with a decrease in measurement level.ConclusionsTAMA is a better biomarker than TPA in terms of inter-scan and inter-reader agreement and robustness to the measurement level. CT was a more reliable imaging modality than MRI. Our results support the use of TAMA measured by CT as a standard biomarker for abdominal muscle area measurement.

Highlights

  • Sarcopenia is characterized by an age-related decline of muscle mass with low muscle strength and/or physical performance, and it has recently been assigned the International Classification of Diseases (ICD-10CM) code [M62.84] [1,2,3]

  • total abdominal muscle area (TAMA) was a more reliable biomarker than total psoas muscle area (TPA) in terms of inter-scan agreement (ICC: 0.928 vs. 0.788 for reader 1 and 0.853 vs. 0.821 for reader 2, respectively; within-subject coefficient of variation (WSCV): 8.3% vs. 23.4% for reader 1 and 10.4% vs. 22.3% for reader 2, respectively) and inter-reader agreement (ICC: 0.986 vs. 0.886 for computed tomography (CT) and 0.865 vs. 0.669 for magnetic resonance imaging (MRI), respectively; WSCV: 8.2% vs. 16.0% for CT and 11.6% vs. 29.7% for MRI, respectively)

  • In terms of the measurement level, TAMA did not differ from the L2inf to L4inf levels, whereas TPA increased with a decrease in measurement level

Read more

Summary

Introduction

Sarcopenia is characterized by an age-related decline of muscle mass with low muscle strength and/or physical performance, and it has recently been assigned the International Classification of Diseases (ICD-10CM) code [M62.84] [1,2,3]. The assessment of muscle and fat tissues is essential in the management of patients with obesity, aging, and wasting diseases [4, 5]. Cross-sectional imaging techniques, such as magnetic resonance imaging (MRI) and computed tomography (CT), are the most reliable methods and regarded as gold standard methods for quantifying the muscle mass and visceral fat area (VFA) or volume. Quantification of abdominal muscle mass by cross-sectional imaging has been increasingly used to diagnose sarcopenia; the technical method for quantification has not been standardized yet. We aimed to determine an optimal method to measure the abdominal muscle area.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call